-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Segments
-
Pharmaceutical
-
Consumer Health
-
MedTech
-
Public Health & Government
-
Payer & Provider
Pharmaceutical (Global page)
Bringing data science and human science together to advance human health and support the pharmaceutical industry from clinical trials to commercialization.
Learn More
Consumer Health
Connecting with powerful, evidence-based market insights to drive agile thinking, uncover growth potential, and gain competitive advantage in this fast-moving consumer health market.
LEARN MORE
MedTech
Empowering to orchestrate operations across the entire product lifecycle, from concept-to-market, providing quality control, regulatory, safety and compliance solutions along the way.
Learn more
Public Health & Government
Working across the health system to address key barriers to deliver high-quality, cost-effective care while improving health outcomes using our data-driven and population-centric solutions.
LEARN MORE
Payer & Provider
Delivering a wide range of consulting and technology solutions to support healthcare stakeholders to drive operational efficiency, enhance quality of patient care, and improve systemic outcomes.
learn moreHealthcare Provider Solutions
Solutions
-
Research & Development
-
Real World Evidence
-
Information Insights
-
Market Research
-
Strategy Consulting
-
Contract Sales & Medical Solutions
-
Patient Solutions
-
AI, Digital & Technology Solutions
Research & Development (Global page)
Clinical development enabled by Connected Intelligence™ which combines data and analytics with deep therapeutic and operational expertise to improve efficiency, enhance precision, and bring therapies to patients faster.
Learn More
Real World Evidence
Harness the power of real-world data and insights to demonstrate value-driven evidence and outcomes to meet stakeholder needs across the healthcare ecosystem and to propel healthcare forward.
LEARN MORE
Information Insights
Pharmaceutical market data and information assets that provide actionable data points to help organizations make intelligent connections and drive healthcare forward.
LEARN MORE
Market Research
Primary Intelligence integrates purpose-built and syndicated research solutions with our wide range of data assets, research methodologies, advanced analytics, and deep domain expertise, generating quality insights for our clients.
LEARN MORE
Strategy Consulting (Global page)
Trusted advisor and partner to global healthcare organisations, solving the most significant business challenges through extensive healthcare expertise.
LEARN MORERelated Solutions
Contract Sales & Medical Solutions (Global page)
Optimize commercial success by leveraging our comprehensive outsourced expertise to accelerate time-to-market.
LEARN MORE
Patient Solutions (Global page)
A single window solution provider to support pharmaco’s design, deploy technology and services that help increase access to medicine and improve treatment adherence.
LEARN MORE
AI, Digital & Technology Solutions
Connected Intelligence™, digital insights, data analytics and advanced technology to power smarter decision-making to enable better patient outcomes and improved business results.
LEARN MOREOur Latest Whitepapers
Get the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreBlogs, Case Studies & Podcasts
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights
IQVIA APAC Insight
"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.
Read The Latest Issue
Featured Event
"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers
Learn MoreCareer Opportunities
Improving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search Jobs
Blog
The past, present and future of China’s internet healthcare ecosystem
Jul 05, 2021
As China recovers from the economic drawbacks caused by the COVID-19 pandemic, we can take a step back and see impact to the development of internet medicine. Much like the effect of SARS on e-commerce in 2003, where e-commerce giants like JD and T-mall (Alibaba) boomed at exponential rates, the COVID-19 pandemic has been a catalyst of growth.
Both encouraging government regulatory policies and innovative technologies, have stimulated the quick growth of internet hospitals. The trigger for the e-commerce boom and rise of internet hospitals is the same: consumers needed safe, efficient, convenient access to products or treatment with minimum human contact. Before 2010, China’s policies did not enable internet hospitals or the ability to purchase medicine online. However, e-commerce platforms started to test the waters of internet hospitals by selling over-the-counter (OTC) products on-line, and the policy changed to allow this but only on selected platforms. Despite a State Food and Drug Administration (SFDA) ban on online prescription drug sales, the “Healthy China 2030” policies highly prioritized internet healthcare at a national strategic planning level. In addition, 5 SFDA approved provinces started to test “distant diagnosis and treatment”.
Finally, in 2018 the ban on selling Rx drugs online was revoked, and was followed by policies and regulations on medicine selling, distant diagnosis and treatment, etc. While, COVID-19 was a catalyst, China was already ready for internet hospitals. During COVID-19, the State Council, the National Health Commission and the National Insurance Bureau emphasized the importance of aggressively expanding and growing the internet hospital practice, backed by Basic Medical Insurance (BMI).
Is China benefitting fully from what internet hospitals have to offer? In reality, this is just the beginning. Eventually there will be a complete internet healthcare ecosystem, with different players contributing and building into the system. Presently, the majority of online sales under the internet hospital umbrella are medicines, ─overall drug sales accounts for over 85% of all internet hospital sales. Other related services such as online registration, consultation, diagnosis and treatment are either not mature enough or limited by a difficulty to see any profit potential.
However, there will be change in China for a more complete internet hospital ecosystem in the near future. The concept of internet healthcare will, over time, grow in scope, acceptance and adoption. The near future will offer us a complete picture put together by pieces from providers in hardware, software, digitalization, AI, big data, among other elements.
For more information on internet hospitals, please feel free to contact us.